Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies...
Regulatory News: This replaces the announcement made at 17:45 on October 31 because the following statement has been deleted: “The limited review procedures for the interim financial statements...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.25 | 0.25 | 0.25 | 0 | 0 | DE |
4 | 0 | 0 | 0.25 | 0.25 | 0.25 | 0 | 0 | DE |
12 | -0.18 | -41.8604651163 | 0.43 | 0.59 | 0.23 | 14034 | 0.38042991 | DE |
26 | -0.35 | -58.3333333333 | 0.6 | 0.89 | 0.22 | 30876 | 0.52252546 | DE |
52 | -2.59 | -91.1971830986 | 2.84 | 5.32 | 0.22 | 52085 | 0.98194987 | DE |
156 | -5.85 | -95.9016393443 | 6.1 | 11 | 0.22 | 19248 | 1.5393299 | DE |
260 | 0.078 | 45.3488372093 | 0.172 | 11 | 0.142 | 60041 | 1.24720036 | DE |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約